medinews (cardiology) limited
medinews (cardiology) limited Company Information
Company Number
03223277
Next Accounts
Sep 2025
Shareholders
omniamed communications limited
Group Structure
View All
Industry
Publishing of consumer, business and professional journals and periodicals
+1Registered Address
ground floor 108 cannon street, london, EC4N 6EU
Website
bjcardio.co.ukmedinews (cardiology) limited Estimated Valuation
Pomanda estimates the enterprise value of MEDINEWS (CARDIOLOGY) LIMITED at £71.4k based on a Turnover of £115.1k and 0.62x industry multiple (adjusted for size and gross margin).
medinews (cardiology) limited Estimated Valuation
Pomanda estimates the enterprise value of MEDINEWS (CARDIOLOGY) LIMITED at £1.2m based on an EBITDA of £351.9k and a 3.34x industry multiple (adjusted for size and gross margin).
medinews (cardiology) limited Estimated Valuation
Pomanda estimates the enterprise value of MEDINEWS (CARDIOLOGY) LIMITED at £829.1k based on Net Assets of £479.8k and 1.73x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Medinews (cardiology) Limited Overview
Medinews (cardiology) Limited is a live company located in london, EC4N 6EU with a Companies House number of 03223277. It operates in the publishing of consumer and business journals and periodicals sector, SIC Code 58142. Founded in July 1996, it's largest shareholder is omniamed communications limited with a 100% stake. Medinews (cardiology) Limited is a mature, micro sized company, Pomanda has estimated its turnover at £115.1k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Medinews (cardiology) Limited Health Check
Pomanda's financial health check has awarded Medinews (Cardiology) Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
5 Weak
Size
annual sales of £115.1k, make it smaller than the average company (£4.1m)
- Medinews (cardiology) Limited
£4.1m - Industry AVG
Growth
3 year (CAGR) sales growth of -31%, show it is growing at a slower rate (1.9%)
- Medinews (cardiology) Limited
1.9% - Industry AVG
Production
with a gross margin of 60%, this company has a comparable cost of product (60%)
- Medinews (cardiology) Limited
60% - Industry AVG
Profitability
an operating margin of 305.5% make it more profitable than the average company (8.9%)
- Medinews (cardiology) Limited
8.9% - Industry AVG
Employees
with 1 employees, this is below the industry average (34)
- Medinews (cardiology) Limited
34 - Industry AVG
Pay Structure
on an average salary of £56.6k, the company has an equivalent pay structure (£56.6k)
- Medinews (cardiology) Limited
£56.6k - Industry AVG
Efficiency
resulting in sales per employee of £115.1k, this is less efficient (£149.6k)
- Medinews (cardiology) Limited
£149.6k - Industry AVG
Debtor Days
it gets paid by customers after 53 days, this is later than average (44 days)
- Medinews (cardiology) Limited
44 days - Industry AVG
Creditor Days
its suppliers are paid after 72 days, this is slower than average (33 days)
- Medinews (cardiology) Limited
33 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Medinews (cardiology) Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 55 weeks, this is more cash available to meet short term requirements (40 weeks)
55 weeks - Medinews (cardiology) Limited
40 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 15.3%, this is a lower level of debt than the average (43.2%)
15.3% - Medinews (cardiology) Limited
43.2% - Industry AVG
MEDINEWS (CARDIOLOGY) LIMITED financials
Medinews (Cardiology) Limited's latest turnover from December 2023 is estimated at £115.1 thousand and the company has net assets of £479.8 thousand. According to their latest financial statements, we estimate that Medinews (Cardiology) Limited has 1 employee and maintains cash reserves of £92.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Jan 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | |||||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | |||||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | |||||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | 3 | 3 | 3 | 2 | 3 | 3 | 3 | ||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Jan 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 154 | 413 | 385 | 721 | 140 | 587 | 690 | 176 | 275 | ||||||
| Intangible Assets | 1,234 | ||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 1,234 | 154 | 413 | 385 | 721 | 140 | 587 | 690 | 176 | 275 | |||||
| Stock & work in progress | |||||||||||||||
| Trade Debtors | 16,846 | 8,681 | 89,174 | 30,379 | 47,460 | 37,918 | 29,296 | 31,810 | 28,193 | 49,673 | 30,638 | 50,423 | 77,694 | 43,057 | 85,270 |
| Group Debtors | 419,227 | 71,957 | |||||||||||||
| Misc Debtors | 36,251 | 5,396 | 4,056 | 1,977 | 6,744 | 9,824 | 2,533 | 1,488 | 11,535 | ||||||
| Cash | 92,881 | 179,837 | 139,148 | 144,692 | 104,930 | 145,000 | 164,078 | 157,375 | 130,902 | 160,694 | 112,316 | 212,259 | 151,996 | 124,457 | 81,687 |
| misc current assets | |||||||||||||||
| total current assets | 565,205 | 265,871 | 232,378 | 177,048 | 159,134 | 192,742 | 195,907 | 190,673 | 170,630 | 210,367 | 142,954 | 262,682 | 229,690 | 167,514 | 166,957 |
| total assets | 566,439 | 266,025 | 232,791 | 177,048 | 159,134 | 192,742 | 195,907 | 190,673 | 171,015 | 211,088 | 143,094 | 263,269 | 230,380 | 167,690 | 167,232 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 9,139 | 8,325 | 4,764 | 5,295 | 3,525 | 20,112 | 17,603 | 15,594 | 25,968 | 72,899 | 22,385 | 103,837 | 84,343 | 35,765 | 30,445 |
| Group/Directors Accounts | 10,086 | ||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 77,190 | 47,018 | 64,669 | 32,380 | 35,488 | 47,125 | 54,004 | 51,965 | 31,017 | ||||||
| total current liabilities | 86,329 | 55,343 | 69,433 | 47,761 | 39,013 | 67,237 | 71,607 | 67,559 | 56,985 | 72,899 | 22,385 | 103,837 | 84,343 | 35,765 | 30,445 |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | 308 | 39 | |||||||||||||
| total long term liabilities | 308 | 39 | |||||||||||||
| total liabilities | 86,637 | 55,382 | 69,433 | 47,761 | 39,013 | 67,237 | 71,607 | 67,559 | 56,985 | 72,899 | 22,385 | 103,837 | 84,343 | 35,765 | 30,445 |
| net assets | 479,802 | 210,643 | 163,358 | 129,287 | 120,121 | 125,505 | 124,300 | 123,114 | 114,030 | 138,189 | 120,709 | 159,432 | 146,037 | 131,925 | 136,787 |
| total shareholders funds | 479,802 | 210,643 | 163,358 | 129,287 | 120,121 | 125,505 | 124,300 | 123,114 | 114,030 | 138,189 | 120,709 | 159,432 | 146,037 | 131,925 | 136,787 |
| Dec 2023 | Dec 2022 | Jan 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 154 | 259 | 160 | 385 | 336 | 417 | 447 | 523 | 406 | 99 | 24 | ||||
| Amortisation | 39 | ||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | 386,290 | 53,678 | 60,874 | -21,848 | 6,462 | 15,913 | -1,469 | -6,430 | -9,945 | 19,035 | -19,785 | -27,271 | 34,637 | -42,213 | 85,270 |
| Creditors | 814 | 3,030 | -531 | 1,770 | -16,587 | 2,509 | 2,009 | -10,374 | -46,931 | 50,514 | -81,452 | 19,494 | 48,578 | 5,320 | 30,445 |
| Accruals and Deferred Income | 30,172 | 14,638 | 32,289 | -3,108 | -11,637 | -6,879 | 2,039 | 20,948 | 31,017 | ||||||
| Deferred Taxes & Provisions | 269 | 39 | |||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -10,086 | -10,086 | 10,086 | ||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | |||||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | -86,956 | 35,145 | -5,544 | 39,762 | -40,070 | -19,078 | 6,703 | 26,473 | -29,792 | 48,378 | -99,943 | 60,263 | 27,539 | 42,770 | 81,687 |
| overdraft | |||||||||||||||
| change in cash | -86,956 | 35,145 | -5,544 | 39,762 | -40,070 | -19,078 | 6,703 | 26,473 | -29,792 | 48,378 | -99,943 | 60,263 | 27,539 | 42,770 | 81,687 |
medinews (cardiology) limited Credit Report and Business Information
Medinews (cardiology) Limited Competitor Analysis
Perform a competitor analysis for medinews (cardiology) limited by selecting its closest rivals, whether from the INFORMATION AND COMMUNICATION sector, other micro companies, companies in EC4N area or any other competitors across 12 key performance metrics.
medinews (cardiology) limited Ownership
MEDINEWS (CARDIOLOGY) LIMITED group structure
Medinews (Cardiology) Limited has no subsidiary companies.
Ultimate parent company
DPE DEUTSCHLAND II A GMBH & CO KG
#0066565
2 parents
MEDINEWS (CARDIOLOGY) LIMITED
03223277
medinews (cardiology) limited directors
Medinews (Cardiology) Limited currently has 2 directors. The longest serving directors include Mr Gerard Nemitz (Feb 2022) and Mr Alexander Beaumont (Feb 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Gerard Nemitz | England | 52 years | Feb 2022 | - | Director |
| Mr Alexander Beaumont | England | 47 years | Feb 2022 | - | Director |
P&L
December 2023turnover
115.1k
+95%
operating profit
351.7k
0%
gross margin
60.1%
-3.02%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
479.8k
+1.28%
total assets
566.4k
+1.13%
cash
92.9k
-0.48%
net assets
Total assets minus all liabilities
medinews (cardiology) limited company details
company number
03223277
Type
Private limited with Share Capital
industry
58142 - Publishing of consumer, business and professional journals and periodicals
58141 - Publishing of learned journals
incorporation date
July 1996
age
29
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2023
previous names
zoneaccent limited (August 1996)
accountant
-
auditor
CROWE U.K LLP
address
ground floor 108 cannon street, london, EC4N 6EU
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
medinews (cardiology) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to medinews (cardiology) limited.
medinews (cardiology) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MEDINEWS (CARDIOLOGY) LIMITED. This can take several minutes, an email will notify you when this has completed.
medinews (cardiology) limited Companies House Filings - See Documents
| date | description | view/download |
|---|
